| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 11.00 | High level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. (Feb 2007) |
| Mutant | Resistances |
|---|---|
| 601-603del |
Ganciclovir:
|
| T601M |
Ganciclovir:
|